IDEXX Laboratories
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,109,457 | $998,427 | $954,288 | $975,543 |
Gross Profit | 694,732 | 623,379 | 570,660 | 596,038 |
EBITDA | 409,445 | 351,813 | 298,563 | 341,999 |
EBIT | 373,673 | 317,750 | 264,857 | 307,866 |
Net Income | 293,989 | 242,677 | 216,149 | 232,841 |
Net Change In Cash | 1,109,457 | 998,427 | 954,288 | 975,543 |
Free Cash Flow | 151,641 | 207,936 | 222,770 | 191,990 |
Cash | 164,594 | 163,970 | 288,266 | 308,636 |
Basic Shares | 80,994 | 81,922 | 83,056 | 83,056 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,897,504 | $3,660,953 | $3,367,324 | $3,215,360 |
Gross Profit | 2,378,927 | 2,189,970 | 2,004,338 | 1,889,432 |
EBITDA | 1,275,840 | 1,097,128 | 1,010,665 | 1,036,624 |
EBIT | 1,145,904 | 1,097,128 | 898,765 | 932,028 |
Net Income | 887,867 | 845,042 | 679,089 | 744,845 |
Net Change In Cash | 3,897,504 | 3,660,953 | 3,367,324 | 3,215,360 |
Cost of Revenue | -23,302 | -234,835 | ||
Free Cash Flow | 798,079 | 772,879 | 394,146 | 635,997 |
Cash | 288,266 | 453,932 | 112,546 | 144,454 |
Basic Shares | 83,056 | 83,978 | 84,600 | 86,572 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $3.50 |
2025-03-31 | $2.96 |
2024-12-31 | $2.62 |
2024-09-30 | $2.80 |
